Lv11
10 积分 2023-10-12 加入
Bispecific T cell engager therapy for refractory rheumatoid arthritis
8小时前
已完结
[Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus (2025 edition)]
9天前
已完结
Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis
1个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
1个月前
已完结
Allogeneic anti-CD19 CAR-T cells induce remission in refractory systemic lupus erythematosus
1个月前
已完结
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
1个月前
已完结
MECHANISMS OF PHAGOCYTOSIS IN MACROPHAGES
1个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
2个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
2个月前
已完结
皖公网安备34019202002308
